Table 3.

Patient Characteristics Associated with OCS Use, According to the Exposure to OCS

	Low-Dose Users (<2.5mg Prednisolone/Day/Year) n=42 (100%)	High-Dose Users (≥2.5mg Prednisolone/Day/Year) n=23 (100%)
Age (years), n (%)
≤65 years	33 (78.6%)	11 (47.8%)
>65 years	9 (21.4%)	12 (52.2%)
Comorbidities [YES]†, n (%)
Conjunctivitis	9 (30.0%)	6 (35.3%)
Osteoporosis	6 (20.0%)	9 (52.9%)
Patients with urgent health care resources use (unscheduled consultations and/or ED visits)‡, n (%)	23 (57.5%)	10 (50.0%)
CARAT score, average (SD)‡	16.1 (7.2)	16.8 (7.1)

Notes: †Missing data=18; ‡Missing data=5.